These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16021171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, Sharpe G, Smith CH, Dobozy A, Turjanmaa K, European Tacrolimus Ointment Study Group.
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Fölster-Holst R, Vena G, Bos JD, Fabbri P, Groenhoej Larsen C, European Tacrolimus Ointment Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [Abstract] [Full Text] [Related]

  • 12. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
    Reitamo S, Ortonne JP, Sand C, Bos J, Cambazard F, Bieber T, Grønhøj-Larsen C, Rustin M, Fölster-Holst R, Schuttelaar M, European Tacrolimus Ointment Study Group.
    Acta Derm Venereol; 2007 Nov; 87(5):406-12. PubMed ID: 17721647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
    Rustin MH.
    Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
    [Abstract] [Full Text] [Related]

  • 17. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR, Vander Straten MR, Korman NJ.
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [Abstract] [Full Text] [Related]

  • 20. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group.
    Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.